TrialPanorama/TrialPanorama-database huggingface dataset:
Study 20452705 — Predictive Biomarker (PRD): ARCN1 mRNA
Genes: ARCN1; COPD
Study 10090348 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 10090348 — Surrogate Endpoint (SUR): Blood pressure
Study 29450585 — Surrogate Endpoint (SUR): Bone mineral density
Study 15005325 — Predictive Biomarker (PRD): Liver iron
Study 8293750 — Surrogate Endpoint (SUR): Blood pressure
Study 25555877 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 25555877 — Surrogate Endpoint (SUR): Blood pressure
Study 11754399 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 9282234 — Surrogate Endpoint (SUR): Forced vital capacity
Study 8102213 — Surrogate Endpoint (SUR): Serum potassium
Study 3557779 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 19820133 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 7515453 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 24610180 — Predictive Biomarker (PRD): TKTL1 mRNA
Genes: TKTL1; TKR; TKT2
Study 22584263 — Predictive Biomarker (PRD): AQP3 mRNA
Genes: AQP3
Study 10326953 — Surrogate Endpoint (SUR): Blood pressure
Study 30706836 — Surrogate Endpoint (SUR): Blood pressure
Study 25416329 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 25066025 — Surrogate Endpoint (SUR): Serum sodium
Study 22210755 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 22210755 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 6337676 — Surrogate Endpoint (SUR): Blood pressure
Study 25090264 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 25090264 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 3330140 — Surrogate Endpoint (SUR): Serum uric acid
Study 29802627 — Surrogate Endpoint (SUR): Probing pocket depth
Study 20663460 — Surrogate Endpoint (SUR): Blood pressure
Study 19726355 — Safety Biomarker (SAF): IL4
Genes: BSF1; IL-4; BCGF1; BCGF-1; MGC79402
Study 19726355 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 30430294 — Predictive Biomarker (PRD): EMB mRNA
Genes: EMB
Study 27206266 — Surrogate Endpoint (SUR): Blood pressure
Study 11863124 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 7591280 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 7591280 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 24622423 — Predictive Biomarker (PRD): EMD mRNA
Genes: EMD; EDMD; STA
Study 24032205 — Predictive Biomarker (PRD): C4A mRNA
Genes: C4A; CO4; CPAMD2
Study 16466168 — Predictive Biomarker (PRD): CHM mRNA
Genes: CHM; REP1; TCD
Study 4019944 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 30513433 — Predictive Biomarker (PRD): RBP4 mRNA
Genes: RBP4; PRO2222
Study 27106715 — Pharmacodynamic Biomarker (PDY): Error related negativity
Study 20091678 — Monitoring Biomarker (MOI): HBV DNA
Study 18166199 — Pharmacodynamic Biomarker (PDY): Survival motor neuron protein
Genes: SMN1; SMN; SMNT;; SMN2; SMNC
Study 8558634 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 8558634 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 8558634 — Predictive Biomarker (PRD): IL2
Genes: IL-2; TCGF
Study 1831394 — Surrogate Endpoint (SUR): Blood pressure
Study 10226860 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 8764421 — Surrogate Endpoint (SUR): Blood pressure
Study 20937312 — Monitoring Biomarker (MOI): HBV DNA
Study 16904536 — Surrogate Endpoint (SUR): Serum creatinine
Study 9025802 — Predictive Biomarker (PRD): SRC mRNA
Genes: SRC; SRC1
Study 12115356 — Predictive Biomarker (PRD): NNT mRNA
Genes: NNT
Study 377476 — Predictive Biomarker (PRD): PIP mRNA
Genes: PIP; GCDFP15; GPIP4
Study 21332729 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 15498085 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 21739700 — Surrogate Endpoint (SUR): Blood pressure
Study 10596307 — Surrogate Endpoint (SUR): Blood pressure
Study 3925887 — Predictive Biomarker (PRD): GPT mRNA
Genes: GPT; AAT1; GPT1
Study 30415298 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 15877874 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 15877874 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 10690292 — Safety Biomarker (SAF): Natriuretic peptides A
Genes: NPPA; ANP; PND
Study 17175181 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 6343726 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study 9456163 — Surrogate Endpoint (SUR): Blood pressure
Study 1013850 — Surrogate Endpoint (SUR): Blood pressure
Study 28555198 — Surrogate Endpoint (SUR): Blood pressure
Study 14626626 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 11061656 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 8168532 — Predictive Biomarker (PRD): SSB mRNA
Genes: SSB
Study 9407641 — Predictive Biomarker (PRD): ALPK1 mRNA
Genes: ALPK1; KIAA1527; LAK
Study 24656944 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study 3917678 — Safety Biomarker (SAF): Beta-2-microglobulin
Genes: B2M; CDABP0092; HDCMA22P
Study 30341345 — Monitoring Biomarker (MOI): HBV DNA
Study 11817518 — Surrogate Endpoint (SUR): Blood pressure
Study 9553478 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 9553478 — Predictive Biomarker (PRD): PTPRC mRNA
Genes: PTPRC; CD45
Study 9553478 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 8157729 — Predictive Biomarker (PRD): TBXT mRNA
Genes: TBXT; T
Study 30722696 — Surrogate Endpoint (SUR): Forced vital capacity
Study 18222354 — Predictive Biomarker (PRD): KIF6 mRNA
Genes: KIF6; C6orf102
Study 18473981 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study 9193330 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 26614676 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 15784032 — Monitoring Biomarker (MOI): HBV DNA
Study 10323814 — Surrogate Endpoint (SUR): Blood pressure
Study 10323814 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 31977643 — Predictive Biomarker (PRD): DIAPH2 mRNA
Genes: DIAPH2; DIA
Study 31188026 — Predictive Biomarker (PRD): SLC2A2 mRNA
Genes: SLC2A2; GLUT2
Study 31188026 — Predictive Biomarker (PRD): SLC47A1 mRNA
Genes: SLC47A1; MATE1
Study 31188026 — Predictive Biomarker (PRD): SLC47A2 mRNA
Genes: SLC47A2; MATE2
Study 31188026 — Predictive Biomarker (PRD): POU2F1 mRNA
Genes: POU2F1; OCT1; OTF1
Study 27290966 — Surrogate Endpoint (SUR): Blood pressure
Study 22954842 — Predictive Biomarker (PRD): CAPS mRNA
Genes: CAPS
Study 21541462 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 21541462 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 11419884 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 27676151 — Surrogate Endpoint (SUR): Blood pressure
Study 24246116 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 20569447 — Predictive Biomarker (PRD): 5HTT
Genes: SLC6A4; 5-HTT; SERT1
Study 9438767 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 9438767 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 8586774 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 2770272 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 2770272 — Predictive Biomarker (PRD): IK mRNA
Genes: IK; RED; RER
Study 25813656 — Predictive Biomarker (PRD): XRN1 mRNA
Genes: XRN1; SEP1
Study 25813656 — Predictive Biomarker (PRD): SEPTIN6 mRNA
Genes: SEPTIN6; KIAA0128; SEP2; SEPT6
Study 25813656 — Predictive Biomarker (PRD): SEPTIN3 mRNA
Genes: SEPTIN3; SEP3; SEPT3
Study 20443395 — Predictive Biomarker (PRD): SDS mRNA
Genes: SDS; SDH
Study 31387606 — Pharmacodynamic Biomarker (PDY): Beta-secretase 1
Genes: BACE1; BACE; KIAA1149
Study 25305042 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 25305042 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 21229331 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study 21229331 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 16477259 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 15140632 — Surrogate Endpoint (SUR): Blood pressure
Study 14514574 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 14514574 — Safety Biomarker (SAF): Antithrombin-III
Genes: SERPINC1; AT3; PRO0309
Study 14514574 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study 10880891 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 1570227 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study 20382637 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 20382637 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 8860096 — Surrogate Endpoint (SUR): Blood pressure
Study 31127611 — Surrogate Endpoint (SUR): Bone mineral density
Study 26810483 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study 17414592 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 17414592 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 30488952 — Surrogate Endpoint (SUR): Probing pocket depth
Study 22661278 — Predictive Biomarker (PRD): MAL mRNA
Genes: MAL
Study 30898134 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 30898134 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 30898134 — Safety Biomarker (SAF): BDNF
Study 30898134 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 28648477 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 23331192 — Surrogate Endpoint (SUR): Bone mineral density
Study 31262924 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 26880679 — Surrogate Endpoint (SUR): Blood pressure
Study 15121021 — Surrogate Endpoint (SUR): Bone mineral density
Study 15121021 — Surrogate Endpoint (SUR): New morphometric vertebral fractures
Study 9461704 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 19931408 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 9057170 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study 30296537 — Predictive Biomarker (PRD): MCC mRNA
Genes: MCC
Study 7769502 — Surrogate Endpoint (SUR): Blood pressure
Study 7769502 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 19566639 — Surrogate Endpoint (SUR): Blood pressure
Study 15292108 — Predictive Biomarker (PRD): OAT mRNA
Genes: OAT
Study 15292108 — Surrogate Endpoint (SUR): Sperm parameters
Study 25421879 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study 31498937 — Surrogate Endpoint (SUR): Bone mineral density
Study 31446994 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 26580275 — Surrogate Endpoint (SUR): Blood pressure
Study 23733488 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study 19130041 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 17998028 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 17998028 — Safety Biomarker (SAF): BDNF
Study 27264211 — Pharmacodynamic Biomarker (PDY): Heat pain threshold
Study 17540969 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 2071264 — Surrogate Endpoint (SUR): Blood pressure
Study 31672712 — Predictive Biomarker (PRD): CPM mRNA
Genes: CPM
Study 21244601 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 21244601 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 12538369 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 8403515 — Predictive Biomarker (PRD): FCGR3B
Genes: CD16; CD16b; FcgammaRIIIb; FcRIIIb
Study 8403515 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 2 receptor alpha
Genes: IL2RA
Study 8403515 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study 15738535 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 2445214 — Surrogate Endpoint (SUR): Serum calcium
Study 21262888 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 21262888 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 9288302 — Predictive Biomarker (PRD): FES mRNA
Genes: FES; FPS
Study 29909698 — Surrogate Endpoint (SUR): Blood pressure
Study 28681550 — Surrogate Endpoint (SUR): Blood pressure
Study 17460370 — Surrogate Endpoint (SUR): Blood pressure
Study 7955239 — Predictive Biomarker (PRD): RITA1 mRNA
Genes: RITA1; C12orf52; RITA; PSEC0043
Study 7955239 — Predictive Biomarker (PRD): LAD1 mRNA
Genes: LAD1; LAD
Study 17054858 — Monitoring Biomarker (MOI): HBV DNA
Study 10801994 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 22732469 — Surrogate Endpoint (SUR): Serum creatinine
Study 9508182 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 31214836 — Surrogate Endpoint (SUR): Bone mineral density
Study 31214836 — Surrogate Endpoint (SUR): Serum intact parathyroid hormone
Study 31214836 — Predictive Biomarker (PRD): Intact parathyroid hormone
Study 27546817 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 27546817 — Surrogate Endpoint (SUR): Blood pressure
Study 2090833 — Surrogate Endpoint (SUR): Blood pressure
Study 2090833 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 2090833 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 31947784 — Safety Biomarker (SAF): Coagulation factor IIa
Genes: F2
Study 24899570 — Safety Biomarker (SAF): Hyaluronic acid
Study 11884002 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 9498886 — Surrogate Endpoint (SUR): Blood pressure
Study 29235894 — Predictive Biomarker (PRD): JAK1 mRNA
Genes: JAK1; JAK1A; JAK1B
Study 29235894 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study 29235894 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study 29235894 — Predictive Biomarker (PRD): IRAK1 mRNA
Genes: IRAK1; IRAK
Study 26823552 — Predictive Biomarker (PRD): NNT mRNA
Genes: NNT
Study 7486086 — Surrogate Endpoint (SUR): Forced vital capacity
Study 22576416 — Surrogate Endpoint (SUR): Bone mineral density
Study 19250558 — Surrogate Endpoint (SUR): Blood pressure
Study 19250558 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 11074735 — Surrogate Endpoint (SUR): Bone mineral density
Study 20100958 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 20100958 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 12241543 — Surrogate Endpoint (SUR): Blood pressure
Study 30391912 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 30391912 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 27206218 — Predictive Biomarker (PRD): ERBB3 mRNA
Genes: ERBB3; HER3
Study 25211297 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 25211297 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study 12856387 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 8897331 — Surrogate Endpoint (SUR): Blood pressure
Study 26434564 — Predictive Biomarker (PRD): ACR mRNA
Genes: ACR; ACRS
Study 17998769 — Surrogate Endpoint (SUR): Blood pressure
Study 15970791 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 10512131 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 28328802 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 25297946 — Predictive Biomarker (PRD): CD63 mRNA
Genes: CD63; MLA1; TSPAN30
Study 23830290 — Predictive Biomarker (PRD): MAEA mRNA
Genes: MAEA; EMP; HLC10; PIG5
Study 23830290 — Safety Biomarker (SAF): Cardiac troponin T
Genes: TNNT2
Study 19016317 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 19016317 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 17570880 — Surrogate Endpoint (SUR): Blood pressure
Study 21646672 — Surrogate Endpoint (SUR): Blood pressure
Study 31189238 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 29180210 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 21979284 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 9537607 — Surrogate Endpoint (SUR): Blood pressure
Study 7990242 — Surrogate Endpoint (SUR): Bone mineral density
Study 23992601 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 31559418 — Surrogate Endpoint (SUR): Blood pressure
Study 20466530 — Predictive Biomarker (PRD): CCR1 mRNA
Genes: CCR1; CMKBR1; CMKR1; SCYAR1
Study 18212717 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study 12860346 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 2963205 — Predictive Biomarker (PRD): CPA1 mRNA
Genes: CPA1; CPA
Study 18547537 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study 18547537 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study 15821644 — Predictive Biomarker (PRD): ITGB2 mRNA
Genes: ITGB2; CD18; MFI7
Study 14747429 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study 11391683 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 1092765 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 26104503 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 21273347 — Predictive Biomarker (PRD): MAX mRNA
Genes: MAX; BHLHD4
Study 12201825 — Predictive Biomarker (PRD): SI mRNA
Genes: SI
Study 2683542 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 31469259 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study 23368701 — Safety Biomarker (SAF): Hyaluronic acid
Study 14679365 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 14679365 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 8299603 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 8299603 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 15627538 — Surrogate Endpoint (SUR): Blood pressure
Study 11877567 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 7773815 — Predictive Biomarker (PRD): CPM mRNA
Genes: CPM
Study 24439191 — Surrogate Endpoint (SUR): Serum creatinine
Study 10979643 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 7612386 — Safety Biomarker (SAF): Interleukin 1
Study 7612386 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 31537689 — Predictive Biomarker (PRD): KMT2D mRNA
Genes: KMT2D; ALR; MLL2; MLL4
Study 31537689 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 21515839 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study 21515839 — Monitoring Biomarker (MOI): Tissue transglutaminase
Genes: TGM2
Study 12975594 — Predictive Biomarker (PRD): ITGB2 mRNA
Genes: ITGB2; CD18; MFI7
Study 10947150 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 10947150 — Predictive Biomarker (PRD): IL6
Genes: IL-6; BSF2; HGF; HSF
Study 10947150 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 26915984 — Surrogate Endpoint (SUR): Forced vital capacity
Study 23093731 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study 20821816 — Surrogate Endpoint (SUR): Blood pressure
Study 8655980 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 30297352 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 20027351 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 15358701 — Predictive Biomarker (PRD): AHR mRNA
Genes: AHR; BHLHE76
Study 9280187 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 9280187 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 9280187 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 17396068 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 17396068 — Surrogate Endpoint (SUR): Blood pressure
Study 12032013 — Surrogate Endpoint (SUR): Blood pressure
Study 7604380 — Predictive Biomarker (PRD): HPN mRNA
Genes: HPN; TMPRSS1
Study 31486447 — Predictive Biomarker (PRD): PPARA mRNA
Genes: PPARA; NR1C1; PPAR
Study 23993887 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study 21247627 — Predictive Biomarker (PRD): Hormone receptor
Study 19930904 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2